Skip to content

Author

N. Sunaga

We have 1 of 213 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.

Current understanding of the epidemiology and biological basis of EGFR-mutant lung cancer in Asia is summarized and the preclinical rationale and emerging clinical evidence supporting combination approaches with chemotherapy, anti-angiogenic agents, and EGFR/MET-directed therapies are discussed.

N. Sunaga, Yoshinori Hasegawa, M. Sato · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.